Vaccines access

About 3 million lives saved in the world every year..., but  1.5 million deaths could be avoided.

Sanofi Pasteur wants everyone to have access to its existing vaccines – no matter where they live.

The cost of vaccine administration, weak health systems, and in some cases conflict, mean that many people living in the world’s poorest countries do not have access to vaccines. We have ongoing partnerships with a number of international organizations including the World Health Organization (WHO), Gavi and the United Nations Children’s Fund (UNICEF), through which we supply vaccines where they are needed most. For them, we have developed adapted presentations and implemented tiered-pricing policies.

THE VACCINE ALLIANCE (Gavi)

Gavi was founded in 2000 by the Bill & Melinda Gates Foundation, the World Bank, WHO, UNICEF and vaccine manufacturers, including Sanofi Pasteur. Committed to saving children’s lives and protecting people’s health through the widespread use of vaccines, GAVI’s driving objective is to make a critical contribution to global immunization goals by supporting immunization programs and health systems, and accelerating the introduction of new vaccines. Sanofi Pasteur shares Gavi’s objectives to improve the infrastructures required for proper vaccine administration and to encourage research and development programs focused on diseases that predominantly affect developing countries, and has historically practiced a policy of tiered pricing to facilitate access to vaccines in Gavi countries.

THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI)

GPEI, spearheaded by national governments, WHO, Rotary International, the United States’ Centers for Disease Control and Prevention (CDC) and UNICEF, is the largest public health initiative the world has ever known. Since 1988, more than two billion children around the world have been immunized against polio thanks to the unprecedented cooperation of more than 200 countries and 20 million volunteers, backed by an international investment of US$11 billion. As a key partner of GPEI, Sanofi Pasteur is fully committed to supporting the initiative. Since 1988, we have provided over 6 billion doses of oral polio vaccine (OPV) to UNICEF and we provide today the vast majority of inactivated polio vaccines (IPV) needed in the frame of WHO’s Polio End Game strategy.

EPIVAC: BUILDING INFRASTRUCTURE

EPIVAC program is a Sanofi Pasteur contribution to the GAVI Alliance. Implemented by the Agence de Médecine Préventive, the program was developed in partnership with national governments of eligible countries and the participating universities (Cocody-Abidjan in Ivory Coast, and Paris-Dauphine in France), in collaboration with the WHO, UNICEF, the Vaccine Fund and other partners working in Africa.

The objective of this program is to train doctors involved in the implementation of immunization programs in eleven Central and West African countries.

By providing medical personnel with crucial training in epidemiology, applied computing, vaccinology, and management of health programs, this diploma course in organization and management of immunization in developing countries will help improve access to vaccines in some of the poorest countries in the world. 

 

For more information, please visit:

Featured Video

 

Nepal introduces IPV in routine immunization program

New title

Watch our Polio Heroes playlist